Want to Ensure Your AOM Spend is Worth the Investment? Create an Effective and Affordable Obesity Program

Given the current 42% US obesity rate and powerful results from the new anti-obesity medications (AOMs), employers and others responsible for healthcare benefits decisions are feeling pressure to add coverage for these expensive AOMs to employee health benefits plans. However, with a recent study showing 65% weight regain after patients stop taking their AOM meds, …



Traditional US Obesity Programs Have Failed Us – But New Science Provides Hope and a Path Forward

There is an intense media focus on the arrival of a new class of Anti Obesity Medications (AOMs) and a robust national discussion to clarify their value (“bang for the buck”) given the mix of positives (significant clinical benefits) and negatives (side effects, weight regain on stopping, and high price tag). This is the first …



Medication Non-Adherence: Unlocking Key Barriers for Lasting Behavior Change

Medication Adherence

Convincing patients with chronic diseases to take their medication correctly and consistently can be difficult. Medication non-adherence creates a variety of maladaptations ranging from treatment failure to dangerous pharmacological interactions, all negatively impacting the patient’s health. The financial costs are also staggering. Hospitalizations caused by non-adherence costs upwards of $100 billion (about $310 per person in the US) annually. Since non-adherence can have many triggers, it is necessary to tackle the problem from both the individual …



Taking Healthcare at Home to the Next Level with More Personalized Care

Healthcare-at-home services, including routine care in the home, remote home monitoring (RHM), and remote therapeutic monitoring (RTM), have exploded onto the healthcare scene. These services have been bolstered by new, post-COVID CPT codes. For example, Medicare-, Medicaid-, and commercial eligibility for RHM is no longer the exception, but the norm. McKinsey estimates, “Up to $265 …